Phase 3 Peripheral Artery Disease Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Improving Mobility After Revascularization in Peripheral Artery Disease
Peripheral Artery Disease
Northwestern University386 enrolled7 locationsNCT06686121
Recruiting
Phase 3
Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee
Peripheral Artery DiseaseCritical Limb Ischemia
Mercator MedSystems, Inc.250 enrolled2 locationsNCT04433572
Recruiting
Phase 3
The COCOA-PAD II Trial
Peripheral Artery Disease
Northwestern University190 enrolled3 locationsNCT04794530